Aurigene: To Separate its Discovery Business

Aurigene is in the process of separating its Discovery Business. More details of the same will be shared in the near future.

The proprietary pipeline comprises:

  • I/O pipeline with several first-in-class small molecule inhibitors
  • Protein degraders for several targets
  • Other programs in:
    • Autoimmune/ inflammation
    • Oncology
    • Bacterial Infections

For additional details contact partnering@aurigene.com